Deng, Shun
Luo, Jianhong
Ouyang, Yongzhong
Xie, Jiangbo
He, Zhuo
Huang, Bo
Bai, Fei
Xiao, Ke
Yin, Bin
Wang, Jinfeng
Xu, Biaoming
Zuo, Chaohui
Funding for this research was provided by:
Chaohui Zuo (KQ2004130)
Article History
Received: 12 December 2021
Accepted: 7 March 2022
First Online: 2 April 2022
Declarations
:
: The protocol was approved by the Ethics Committee of The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/ Hunan Cancer Hospital, Changsha, Hunan, China. All participants obtained written informed consent. All procedures conducted in studies involving human participants were in accordance with the ethical standards of the institutions and/or the National Research Council and with the 1964 Declaration of Helsinki and subsequent amendments or similar ethical standards. This article does not include any studies conducted by the authors on animals.
: Written informed consent was obtained from the patients’ guardians for publication of clinical data.
: The authors have no conflicts of interest to declare.